Skip to main content

Table 1 The IC50 values and targets of the approved kinase inhibitors against PDGFRs

From: PDGF/PDGFR effects in osteosarcoma and the “add-on” strategy

Kinase name

Imatinib

Dasatinib

Nilotinib

Sorafenib

Sunitinib

Pazopanib

IC50 values

 PDGFR-α [49]

2.5

2.6

2.4

1.0

13

20

 PDGFR-α [T674I] [50]

8500

 

4100

100

19

170

 PDGFR-α [V561D] [50]

9.1

2.9

15

5.6

14

21

 PDGFR-β [53]

68

1.1

60

34

5.7

42

Primary targets [53, 54]

Abl, PDGFR, Kit

Abl, Src

Kit, Abl, PDGFR

Raf, VEGFR, PDGFR, Kit, Flt3

PDGFR, VEGFR, Kit, Flt3

VEGFR, PDGFR, Kit

Secondary targets [53, 54]

Raf

PDGFR, Kit

   

FGFR

  1. Primary targets: The targets that are inhibited at the lowest concentrations (regardless of absolute concentrations)
  2. Secondary targets: The targets that are inhibited by about tenfold higher inhibitor concentrations